首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1424052

皮質類固醇市場、份額、規模、趨勢、產業分析報告：按類型、給藥途徑、應用、地區、細分市場預測，2024-2032

Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032

出版日期: 2024年01月24日 | 出版商:

Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據Polaris Market Research的最新研究，到2032年，全球皮質類固醇市場規模預計將達到85.3億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

氣喘、類風濕關節炎和皮膚病等慢性疾病的激增正在推動皮質類固醇市場的機會。皮質類固醇由於其強大的抗發炎特性而在這些疾病的治療中至關重要，並且在全世界範圍內需求量很大。在生活方式因素的推動下，對有效抗發炎解決方案的需求已將皮質類固醇置於最前線。製藥創新至關重要，它使公司能夠開發針對特定慢性疾病的配方，並滿足皮質類固醇市場對標靶治療解決方案日益增長的需求。

皮質類固醇市場正在利用生物製劑和聯合療法潛在整合所帶來的機會。具有標靶機制的生物製劑可以與皮質類固醇的廣泛抗發炎作用產生協同作用，旨在改善治療結果並減少副作用。多樣化的治療方式對於自體免疫和發炎性疾病的動態變化至關重要。作用於特定途徑的生物製劑為皮質類固醇治療增添了個人化維度。這個策略組合將推動新配方和治療方案的開發，為管理複雜的疾病狀況提供更有效和量身定制的解決方案，並推動皮質類固醇市場的逐步變革，有望提高治療效果。

遠距醫療和電子醫療在塑造皮質類固醇市場方面變得越來越重要，帶來了新的機會。醫療保健的數位化使遠距諮詢成為可能，並方便了獲得皮質類固醇處方。這些平台使醫療保健提供者能夠監測患者並確保及時調整皮質類固醇治療方案。

電子醫療解決方案簡化了資訊流，並加強了患者對皮質類固醇使用和副作用的教育。這種數位整合不僅會提高患者的依從性，還會擴大皮質類固醇治療的採用，特別是有利於服務不足的人。透過利用遠距醫療提供的便利性和效率，皮質類固醇市場培育了以患者為中心的方法，為創新、數據驅動的見解和增強醫療保健的可近性鋪平了道路。

腎上腺皮質類固醇市場報告亮點

到 2023 年，糖皮質激素領域因其多功能性、慢性病管理和治療進展而佔據了重要的市場份額。

2023年，由於抑制全身吸收、局部治療以及與其他治療的兼容性，外用細分市場佔據了很大的市場份額。

2023 年，皮膚過敏領域因其抗炎特性、快速症狀緩解和廣泛的應用而佔據了主要收入份額。

2023 年，北美地區憑藉其成熟的公司、監管環境、持續的技術進步和研發，在全球市場佔據主導地位。

全球市場參與者包括AbbVie Inc.、AstraZeneca plc、Bayer AG、Cipla Limited、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Sanofi S.A.。因此，市場競爭非常激烈。

皮質類固醇市場 - 應用概況
皮質類固醇市場動態
- 促進因素和機會
  - 藥物配方的進步預計將刺激對該產品的需求
  - 人口老化的加劇預計將推動市場成長
- 抑制因素和挑戰
  - 副作用和副作用可能會阻礙市場成長
PESTEL 分析
皮質類固醇市場應用趨勢
價值鏈分析
COVID-19 感染的影響分析

第 5 章全球皮質類固醇市場，依給藥途徑劃分

主要發現
簡介
吸入
局部
注射
口頭

第 6 章全球皮質類固醇市場，依類型

主要發現
簡介
鹽皮質激素
糖皮質激素

第 7 章全球皮質類固醇市場，依應用劃分

主要發現
簡介
皮膚過敏
胃腸病學
內分泌科
急性呼吸道疾病
風濕病適應症
其他

第 8 章全球皮質類固醇市場（按地區）

主要發現
簡介
- 2019-2032 年皮質類固醇市場評估（按地區）
皮質類固醇市場 - 北美
- 北美：皮質類固醇市場，依給藥途徑劃分，2019-2032 年
- 北美：皮質類固醇市場，依應用分類，2019-2032 年
- 北美：皮質類固醇市場，依類型，2019-2032 年
- 皮質類固醇市場 - 美國
- 皮質類固醇市場 - 加拿大
皮質類固醇市場 - 歐洲
- 歐洲：皮質類固醇市場，依給藥途徑劃分，2019-2032 年
- 歐洲：皮質類固醇市場，按應用劃分，2019-2032 年
- 歐洲：皮質類固醇市場，按類型，2019-2032 年
- 皮質類固醇市場 - 英國
- 皮質類固醇市場 - 法國
- 皮質類固醇市場 - 德國
- 皮質類固醇市場 - 義大利
- 皮質類固醇市場 - 西班牙
- 皮質類固醇市場 - 荷蘭
- 皮質類固醇市場 - 俄羅斯
皮質類固醇市場 - 亞太地區
- 亞太地區：皮質類固醇市場，依給藥途徑劃分，2019-2032 年
- 亞太地區：皮質類固醇市場，依應用劃分，2019-2032 年
- 亞太地區：皮質類固醇市場，依類型，2019-2032 年
- 皮質類固醇市場 - 中國
- 皮質類固醇市場 - 印度
- 皮質類固醇市場 - 馬來西亞
- 皮質類固醇市場 - 日本
- 皮質類固醇市場 - 印尼
- 皮質類固醇市場 - 韓國
皮質類固醇市場 - 中東和非洲
- 中東與非洲：皮質類固醇市場，依給藥途徑劃分，2019-2032 年
- 中東和非洲：皮質類固醇市場，按應用劃分，2019-2032 年
- 中東和非洲：皮質類固醇市場，按類型，2019-2032 年
- 皮質類固醇市場－沙烏地阿拉伯
- 皮質類固醇市場－阿拉伯聯合大公國
- 皮質類固醇市場 - 以色列
- 皮質類固醇市場 - 南非
皮質類固醇市場 - 拉丁美洲
- 拉丁美洲：皮質類固醇市場，依給藥途徑劃分，2019-2032 年
- 拉丁美洲：皮質類固醇市場，按應用劃分，2019-2032 年
- 拉丁美洲：皮質類固醇市場，依類型，2019-2032 年
- 皮質類固醇市場 - 墨西哥
- 皮質類固醇市場 - 巴西
- 皮質類固醇市場 - 阿根廷

第 9 章競爭態勢

擴張與收購分析
- 擴大
- 收購
夥伴關係/協作/協議/揭露

第 10 章公司簡介

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bausch Health Companies Inc.
Bayer AG
Cipla Limited
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Lupin Limited
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.

簡介目錄圖表

Product Code: PM4413

The global Corticosteroids market size is expected to reach USD 8.53 billion by 2032, according to a new study by Polaris Market Research. The report "Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surging prevalence of chronic diseases such as asthma, rheumatoid arthritis, and dermatological disorders propels opportunities in the corticosteroids market. Vital for managing these conditions due to their potent anti-inflammatory properties, corticosteroids witness rising demand globally. Fueled by lifestyle factors, the demand for effective anti-inflammatory solutions positions corticosteroids at the forefront. Pharmaceutical innovation becomes crucial, presenting companies with the prospect of developing tailored formulations for specific chronic diseases, meeting the growing need for targeted therapeutic solutions in the corticosteroids market.

The corticosteroids market is capitalizing on opportunities presented by the potential integration of biologics and combination therapies. Biologics, with targeted mechanisms, synergize with the broad anti-inflammatory actions of corticosteroids, aiming for enhanced therapeutic outcomes and reduced side effects. In the dynamic landscape of autoimmune and inflammatory disorders, diversified treatment modalities are crucial. Biologics, addressing specific pathways, add a personalized dimension to corticosteroid treatments. This strategic combination fosters the development of novel formulations and treatment regimens, offering more effective and tailored solutions for managing complex conditions, marking a progressive shift in the corticosteroids market and promising improved therapeutic efficacy.

Telemedicine and E-Health are increasingly pivotal in shaping the corticosteroids market, opening novel opportunities. The digital transformation in healthcare allows for remote consultations, facilitating easier access to corticosteroid prescriptions. These platforms empower healthcare providers to monitor patients, ensuring timely adjustments to corticosteroid regimens.

E-Health solutions streamline information flow, enhancing patient education on corticosteroid usage and side effects. This digital integration not only boosts patient adherence but also broadens the reach of corticosteroid therapies, particularly benefiting underserved populations. The corticosteroids market capitalizes on the convenience and efficiency introduced by telemedicine, fostering a patient-centric approach and creating avenues for innovation, data-driven insights, and enhanced healthcare accessibility.

Corticosteroids Market Report Highlights

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

Polaris Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Mineralocorticoids
Glucocorticoids

Corticosteroids, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Inhaled
Topical
Injectable
Oral

Corticosteroids, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Skin Allergies
Gastroenterology
Endocrinology
Acute Respiratory Diseases
Rheumatology Indications
Others

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Corticosteroids Market Insights

4.1. Corticosteroids Market - Application Snapshot
4.2. Corticosteroids Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in drug formulations are projected to spur the product demand
  - 4.2.1.2. Rising aging population is expected to drive market growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Adverse reactions and side effects are likely to impede the market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Corticosteroids Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Corticosteroids Market, by Route of Administration

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
5.3. Inhaled
- 5.3.1. Global Corticosteroids Market, by Inhaled, by Region, 2019-2032 (USD Billion)
5.4. Topical
- 5.4.1. Global Corticosteroids Market, by Topical, by Region, 2019-2032 (USD Billion)
5.5. Injectable
- 5.5.1. Global Corticosteroids Market, by Injectable, by Region, 2019-2032 (USD Billion)
5.6. Oral
- 5.6.1. Global Corticosteroids Market, by Oral, by Region, 2019-2032 (USD Billion)

6. Global Corticosteroids Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
6.3. Mineralocorticoids
- 6.3.1. Global Corticosteroids Market, by Mineralocorticoids, by Region, 2019-2032 (USD Billion)
6.4. Glucocorticoids
- 6.4.1. Global Corticosteroids Market, by Glucocorticoids, by Region, 2019-2032 (USD Billion)

7. Global Corticosteroids Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
7.3. Skin Allergies
- 7.3.1. Global Corticosteroids Market, by Skin Allergies, By Region, 2019-2032 (USD Billion)
7.4. Gastroenterology
- 7.4.1. Global Corticosteroids Market, by Gastroenterology, By Region, 2019-2032 (USD Billion)
7.5. Endocrinology
- 7.5.1. Global Corticosteroids Market, by Endocrinology, By Region, 2019-2032 (USD Billion)
7.6. Acute Respiratory Diseases
- 7.6.1. Global Corticosteroids Market, by Acute Respiratory Diseases, By Region, 2019-2032 (USD Billion)
7.7. Rheumatology Indications
- 7.7.1. Global Corticosteroids Market, by Rheumatology Indications, By Region, 2019-2032 (USD Billion)
7.8. Others
- 7.8.1. Global Corticosteroids Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Corticosteroids Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Corticosteroids Market - North America
- 8.3.1. North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.2. North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.3.4. Corticosteroids Market - U.S.
  - 8.3.4.1. U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.3.4.2. U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.3.4.3. U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.3.5. Corticosteroids Market - Canada
  - 8.3.5.1. Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.3.5.2. Canada.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.3.5.3. Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
8.4. Corticosteroids Market - Europe
- 8.4.1. Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.4. Corticosteroids Market - UK
  - 8.4.4.1. UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.4.2. UK.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.4.3. UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.5. Corticosteroids Market - France
  - 8.4.5.1. France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.5.2. France.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.5.3. France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.6. Corticosteroids Market - Germany
  - 8.4.6.1. Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.6.2. Germany.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.6.3. Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.7. Corticosteroids Market - Italy
  - 8.4.7.1. Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.7.2. Italy.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.7.3. Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.8. Corticosteroids Market - Spain
  - 8.4.8.1. Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.8.2. Spain.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.8.3. Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.9. Corticosteroids Market - Netherlands
  - 8.4.9.1. Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.9.2. Netherlands.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.9.3. Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.4.10. Corticosteroids Market - Russia
  - 8.4.10.1. Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.4.10.2. Russia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.4.10.3. Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
8.5. Corticosteroids Market - Asia Pacific
- 8.5.1. Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.4. Corticosteroids Market - China
  - 8.5.4.1. China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.4.2. China.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.4.3. China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.5. Corticosteroids Market - India
  - 8.5.5.1. India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.5.2. India.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.5.3. India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.6. Corticosteroids Market - Malaysia
  - 8.5.6.1. Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.6.2. Malaysia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.6.3. Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.7. Corticosteroids Market - Japan
  - 8.5.7.1. Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.7.2. Japan.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.7.3. Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.8. Corticosteroids Market - Indonesia
  - 8.5.8.1. Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.8.2. Indonesia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.8.3. Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.5.9. Corticosteroids Market - South Korea
  - 8.5.9.1. South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.5.9.2. South Korea.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.5.9.3. South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
8.6. Corticosteroids Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.6.4. Corticosteroids Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.6.5. Corticosteroids Market - UAE
  - 8.6.5.1. UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.6.5.2. UAE.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.6.5.3. UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.6.6. Corticosteroids Market - Israel
  - 8.6.6.1. Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.6.6.2. Israel.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.6.6.3. Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.6.7. Corticosteroids Market - South Africa
  - 8.6.7.1. South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.6.7.2. South Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.6.7.3. South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
8.7. Corticosteroids Market - Latin America
- 8.7.1. Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.7.4. Corticosteroids Market - Mexico
  - 8.7.4.1. Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.7.4.2. Mexico.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.7.4.3. Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.7.5. Corticosteroids Market - Brazil
  - 8.7.5.1. Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.7.5.2. Brazil.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.7.5.3. Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
- 8.7.6. Corticosteroids Market - Argentina
  - 8.7.6.1. Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  - 8.7.6.2. Argentina.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  - 8.7.6.3. Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. AbbVie Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Astellas Pharma Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. AstraZeneca plc
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bausch Health Companies Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Bayer AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Cipla Limited
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Eli Lilly and Company
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. F. Hoffmann-La Roche Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. GlaxoSmithKline plc
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Johnson & Johnson
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Lupin Limited
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Merck & Co., Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Novartis International AG
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Pfizer Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Sanofi S.A.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 2 Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 3 Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 4 Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 5 North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 6 North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 7 North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 8 U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 9 U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 10 U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 11 Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 12 Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 13 Canada: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 14 Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 15 Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 16 Europe: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 17 UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 18 UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 19 UK: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 20 France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 21 France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 22 France: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 23 Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 24 Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 25 Germany: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 26 Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 27 Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 28 Italy: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 29 Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 30 Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 31 Spain: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 32 Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 33 Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 34 Netherlands: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 35 Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 36 Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 37 Russia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 38 Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 39 Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 40 Asia Pacific: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 41 China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 42 China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 43 China: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 44 India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 45 India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 46 India: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 47 Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 48 Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 49 Malaysia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 50 Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 51 Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 52 Japan: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 53 Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 54 Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 55 Indonesia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 56 South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 57 South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 58 South Korea: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 59 Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 60 Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 61 Middle East & Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 62 Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 63 Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 64 Saudi Arabia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 65 UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 66 UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 67 UAE: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 68 Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 69 Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 70 Israel: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 71 South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 72 South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 73 South Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 74 Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 75 Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 76 Latin America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 77 Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 78 Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 79 Mexico: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 80 Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 81 Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 82 Brazil: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
Table 83 Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
Table 84 Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
Table 85 Argentina: Corticosteroids Market, by Application, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Corticosteroids Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Corticosteroids Market, by Type, 2022 & 2032 (USD Billion)
Figure 8. Market by Route of Administration
Figure 9. Global Corticosteroids Market, by Route of Administration, 2022 & 2032 (USD Billion)
Figure 10. Market by Application
Figure 11. Global Corticosteroids Market, by Application, 2022 & 2032 (USD Billion)
Figure 12. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 13. Strategic Analysis - Corticosteroids Market